Monoclonal autoantibodies specific for oxidized phospholipids or oxidized phospholipid-protein adducts inhibit macrophage uptake of oxidized low-density lipoproteins

Journal of Clinical Investigation

Volumn 103, Issue 1, 1999, Pages 117-128

  Hörkkö, Sohvi ^a   Bird, David A ^a   Miller, Elizabeth ^a   Itabe, Hiroyuki ^b   Leitinger, Norbert ^c   Subbanagounder, Ganesamoorthy ^c   Berliner, Judith A ^c   Friedman, Peter ^d   Dennis, Edward A ^d   Curtiss, Linda K ^e   Palinski, Wulf ^a   Witztum, Joseph L ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b TEIKYO UNIVERSITY   (Japan)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; ARACHIDONIC ACID; AUTOANTIBODY; BOVINE SERUM ALBUMIN; CHOLESTEROL ESTER; CHOLESTEROL OLEATE; COPPER; EPITOPE; IMMUNOGLOBULIN M ANTIBODY; LINOLEIC ACID; LOW DENSITY LIPOPROTEIN; MALONALDEHYDE; MONOCLONAL ANTIBODY; PHOSPHATIDYLCHOLINE; PHOSPHOLIPID;

ANIMAL CELL; ANTIGEN BINDING; ARTICLE; CONTROLLED STUDY; FEMALE; IMMUNOASSAY; MACROPHAGE; MOUSE; NONHUMAN; OXIDATION; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL;

EID: 0037896283     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI4533     Document Type: Article

References (43)

1. Palinski, W., et al. 1989. Low density lipoprotein undergoes oxidative modification in vivo. Proc. Natl. Acad. Sci. USA. 86:1372-1376.
2. Ylä-Herttuala, S., et al. 1989. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J. Clin. Invest. 84:1086-1095.
3. Ylä-Herttuala, S., Palinski, W., Rosenfeld, M.E., Steinberg, D., and Witztum, J.L. 1990. Lipoproteins in normal and atherosclerotic aorta. Eur. Heart J. 11 (Suppl. E):88-99.
4. Haberland, M.E., Fong, D., and Cheng, L. 1988. Malondialdehyde-altered protein occurs in atheroma of Watanabe heritable hyperlipidemic rabbits. Science. 241:215-218.
5. Boyd, H.C., Gown, A.M., Wolfbauer, G., and Chair, A. 1989. Direct evidence for a protein recognized by a monoclonal antibody against oxidatively modified LDL in atherosclerotic lesions from a Watanabe heritable hyperlipidemia rabbit. Am. J. Pathol. 135:815-825.
6. Rosenfeld, M.E., Palinski, W., Ylä-Herttuala, S., Butlet, S., and Witztum, J.L. 1990. Distribution of oxidation specific lipid-protein adducts and apolipoprotein B in atherosclerotic lesions of varying severity from WHHL rabbits. Arteriosclerosis. 10:336-349.
7. Hammer, A., et al. 1995. Generation, characterization, and histochemical application of monoclonal antibodies selectively recognizing oxidatively modified apoB-containing serum lipoproteins. Arterioscler. Thromb. Vasc. Biol. 15:704-713.
8. Palinski, W., et al. 1994. Apoprotein E-deficient mice are a model of lipoprotein oxidation in atherogenesis: demonstration of oxidation-specific epitopes in lesions and high titers of autoantibodies to malondi-aldehyde-lysine in serum. Arterioscler. Thromb. 14:605-615.
9. Palinski, W., Tangirala, R.K., Miller, E., Young, S.G., and Witztum, J.L. 1995. Increased autoantibody titers against epitopes of oxidized low density lipoprotein in LDL receptor-deficient mice with increased atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 15:1569-1576.
10. Palinski, W., et al. 1996. Cloning of monoclonal autoantibodies to epitopes of oxidized lipoproteins from apo E-deficient mice. Demonstration of epitopes of oxidized LDL in human plasma. J. Clin. Invest. 98:800-814.
11. Itabe, H., et al. 1996. Sensitive detection of Oxidatively modified low density lipoprotein using a monoclonal antibody. J. Lipid Res. 37:45-53.
12. Tamai, O., et al. 1997. Single LDL apheresis improves endothelium-dependent vasodilatation in hypercholesterolemic humans. Circulation. 95:76-82.
13. Holvoet, P., Theilmeier, G., Shivalkar, B., Flameng, W., and Collen, D. 1998. LDL hypercholesterolemia is associated with accumulation of oxidized LDL, atherosclerotic plaque growth, and compensatory vessel enlargement in coronary arteries of miniature pigs. Arterioscler. Thromb. Vasc. Biol. 18:415-422.
14. Sevanian, A., et al. 1997. LDL- is a lipid hydroperoxide-enriched circulating lipoprotein. J. Lipid. Res. 38:419-428.
15. Quinn, M.T., Parthasarathy, S., Fong, L.G., and Steinberg, D. 1987. Oxidatively modified low density lipoproteins: a potential role in recruitment and retention of monocyte/macrophages during atherogenesis. Proc. Natl. Acad. Sci. USA. 84:2995-2998.
16. McMurray, H.F., Parthasarathy, S., and Steinberg, D. 1993. Oxidatively modified low density lipoprotein is a chemoattractant for human T lymphocytes. J. Clin. Invest. 92:1004-1008.
17. Hessler, J.R., Morel, D.W., Lewis, L.J., and Chisolm, G.M. 1983. Lipoprotein oxidation and lipoprotein-induced cytotoxicity. Arteriosclerosis. 3:215-222.
18. Rajavashisth, T.B., et al. 1990. Induction of endothelialcell expression of granulocyte and macrophage colony-stimulating factors by modified low-density lipoproteins. Nature. 344:254-257.
19. Cushing, S. D., et al. 1990. Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells. Proc. Natl. Acad. Sci. USA. 87:5134-5138.
20. Esterbauer, H., Gebicki, J., Puhl, H., and Jürgens, G. 1992. The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Radical Biol. Med. 13:341-390.
21. Hörkkö, S., et al. 1996. Antiphospholipid antibodies are directed against epitopes of oxidized phospholipids: recognition of cardiolipin by monoclonal antibodies to epitopes of oxidized low-density lipoprotein. J. Clin. Invest. 98:815-825.
22. Fong, L.G., Parthasarathy, S., Witztum, J.L., and Steinberg, D. 1987. Nonenzymatic oxidative cleavage of peptide bonds in apoprotein B-100. J. Lipid Res. 28:1466-1477.
23. Palinski, W., et al. 1990. Antisera and monoclonal antibodies specific for epitopes generated during oxidative modification of low density lipoprotein. Arteriosclerosis. 10:325-335.
24. Parthasarathy, S., Fong, L.G., Otero, D., and Steinberg, D. 1987. Recognition of solubilized apoproteins from delipidated, oxidized low density lipoprotein (LDL) by the acetyl-LDL receptor. Proc. Natl. Acad. Sci. USA. 84:537-540.
25. Terpstra, V., Bird, D., and Steinberg, D. 1998 Evidence that the lipid moiety of oxidized low density lipoprotein plays a role in its interaction with macrophage receptors. Proc. Natl. Acad. Sci. USA. 95:1806-1811.
26. Itabe, H., et al. 1994. A monoclonal antibody against oxidized lipoprotein recognizes foam cells in atherosclerotic lesions. J. Biol. Chem. 269:15274-15279.
27. Etabe, H., et al. 1996. Oxidized phosphatidylcholines that modify proteins. Analysis by monoclonal antibody against oxidized low density lipoprotein. J. Biol. Chem. 271:33208-33217.
28. Watson, A.D., et al. 1997. Structural identification by mass spectrometry of oxidized phospholipids in minimally oxidized low density lipoprotein that induce monocyce/endothelial interactions and evidence for their presence in vivo. J. Biol. Chem. 272:13597-13607.
29. Young, S.G., Witztum, J.L., Casal, D.C., Curtiss, L.K., and Bernstein, S. 1986. Conservation of the low density lipoprotein receptor-binding domain of apoprotein B. Demonstration by a new monoclonal antibody, MB47. Arteriosclerosis. 6:178-188.
30. Hörkkö, S., Miller, E., Branch, D.W., Palinski, W., and Witztum, J.L. 1997. The epitopes for some antiphospholipid antibodies are adducts of oxidized phospholipid and beta-2 glycoprotein 1 (and other proteins). Proc. Natl. Acad. Sci. USA. 94:10356-10361.
31. Reaven, P., et al. 1993. Effects of oleate-rich and linoleate-rich diets on the susceptibility of low density lipopotein to oxidative modification in mildly hypercholesterolemic subjects. J. Clin. Invest. 91:668-676.
32. Goldstern, J.L, Basu, S.K., and Brown, M.S. 1983. Receptor-mediated endocytosis of low-density lipoprotein in cultured cells. Methods Enzymol. 98:241-260.
33. Lowry, O.H., Rosebrough, N.J., Fart, A.L. and Randall, R.J. 1951. Protein measurement with the Folin phenol reagent. J Biol. Chem. 193:265-275.
34. Esterbauer, H., Dieber-Rotheneder, M., Waeg, G., Striegl, G., and Jurgens, G. 1990. Biochemical, structural, and functional properties of oxidized low-density lipoprotein. Chem. Res. Toxicol. 3:77-92.
35. Steinbrecher, U.P., Witztum, J.L., Parthasarathy, S., and Steinberg, D. 1987. Decrease in reactive amino groups during oxidation or endothelial cell modification of LDL. Correlation with changes in receptor-mediated catabolism. Arteriosclerosis. 7:135-143.
36. Zhang, H., Yang, Y., and Steinbrecher, U.P. 1993. Structural requirements for the binding of modified proteins to the scavenger receptor of macrophages. J. Biol. Chem. 268:5535-5542.
37. Hoppe, G., O'Neil, J., Sayre, L.M., and Hoff, H.F. 1997. Non-conventional modification of low density lipoproteins: chemical models for marcophage recognition of oxidized LDL. Biochim. Biophys. Acta. 1362:103-108.
38. Palinski, W., Miller, E., and Witztum, L.J. 1995. Emmunization of LDL receptor-deficient rabbits with homologous malondialdehyde-modified LDL reduces atherogenesis. Proc. Natl. Acad. Sci. USA. 92:821-825.
39. Nilsson, J., et al. 1997. Immunization with homologous oxidized low density lipoprotein reduces neointimal formation after balloon injury in hypercholesterolemic rabbits. J. Am. Coll. Cardiol. 30:1886-1891.
40. Ameli, S., et al. 1996. Effect of immunization with homologous LDL and oxidized LDL on early atherosclerosis in hypercholesterolemic rabbits. Arterioscler. Thromb. Vasc. Biol. 16:1074-1079.
41. George, J., et al. 1998. Hyperimmunization of apo-E-deficient mice with homologous malondialdehyde low-density lipoprotein suppresses early atherogenesis. Atherosclerosis. 138:147-152.
42. Freigang, S., Hörkkö, S., Miller, E., Witztum, J.L., and Palinski, W. 1998. Immunization of LDL receptor-deficient mice with homologous malondialdehyde-modified and native LDL reduces progression of atherosclerosis by mechanisms other than the induction of high titers of antibodies to oxidative neoepitopes. Arterioscler. Thromb. Vasc. Biol. In press.
43. Salonen, J.T., et al. 1992. Autoantibody against oxidised LDL and progression of carotid atherosclerosis. Lancet. 339:883-887.